Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial.
EPIDEMIOLOGY
EPIGENETIC
METHYLATION
OSTEOPOROSIS
RXRA
VITAMIN D
Journal
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
ISSN: 1523-4681
Titre abrégé: J Bone Miner Res
Pays: United States
ID NLM: 8610640
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
11
05
2018
revised:
10
10
2018
accepted:
06
10
2018
pubmed:
16
10
2018
medline:
28
5
2020
entrez:
16
10
2018
Statut:
ppublish
Résumé
We have previously demonstrated inverse associations between maternal 25(OH)-vitamin D status and perinatal DNA methylation at the retinoid-X-receptor-alpha (RXRA) locus and between RXRA methylation and offspring bone mass. In this study, we used an existing randomized trial to test the hypothesis that maternal gestational vitamin D supplementation would lead to reduced perinatal RXRA locus DNA methylation. The Maternal Vitamin D Osteoporosis Study (MAVIDOS) was a multicenter, double-blind, randomized, placebo-controlled trial of 1000 IU/day cholecalciferol or matched placebo from 14 weeks' gestation until delivery. Umbilical cord (fetal) tissue was collected at birth and frozen at -80°C (n = 453). Pyrosequencing was used to undertake DNA methylation analysis at 10 CpG sites within the RXRA locus (identified previously). T tests were used to assess differences between treatment groups in methylation at the three most representative CpG sites. Overall, methylation levels were significantly lower in the umbilical cord from offspring of cholecalciferol-supplemented mothers, reaching statistical significance at four CpG sites, represented by CpG5: mean difference in % methylation between the supplemented and placebo groups was -1.98% (95% CI, -3.65 to -0.32, p = 0.02). ENCODE (Encyclopedia of DNA Elements) evidence supports the functionality of this locus with strong DNase hypersensitivity and enhancer chromatin within biologically relevant cell types including osteoblasts. Enrichment of the enhancer-related H3K4me1 histone mark is also seen in this region, as are binding sites for a range of transcription factors with roles in cell proliferation, response to stress, and growth factors. Our findings are consistent with previous observational results and provide new evidence that maternal gestational supplementation with cholecalciferol leads to altered perinatal epigenetic marking, informing mechanistic understanding of early life mechanisms related to maternal vitamin D status, epigenetic marks, and bone development. © 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.
Identifiants
pubmed: 30321476
doi: 10.1002/jbmr.3603
pmc: PMC6372078
mid: EMS80328
doi:
Substances chimiques
RXRA protein, human
0
Retinoid X Receptor alpha
0
Vitamin D
1406-16-2
25-hydroxyvitamin D
A288AR3C9H
Banques de données
ISRCTN
['ISRCTN82927713']
EudraCT
['2007‐001716‐23']
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
231-240Subventions
Organisme : Medical Research Council
ID : MC_UP_A620_1015
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U105960371
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201222/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A620_1014
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/P028179/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585827
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201268/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585824
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/15/17/31749
Pays : United Kingdom
Organisme : Medical Research Council
ID : 4050502589
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0400491
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585819
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/2
Pays : United Kingdom
Organisme : Department of Health
ID : 10/33/04
Pays : United Kingdom
Organisme : Arthritis Research UK
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 17702
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 21231
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A620_1017
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.
Références
Trials. 2012 Feb 07;13:13
pubmed: 22314083
Clin Epigenetics. 2016 Aug 03;7:83
pubmed: 27493699
J Pediatr. 2013 May;162(5):1004-9.e1
pubmed: 23219444
J Clin Endocrinol Metab. 2014 Sep;99(9):3373-81
pubmed: 24885631
Nat Biotechnol. 2016 Jul;34(7):726-37
pubmed: 27347756
Lancet. 2006 Jan 7;367(9504):36-43
pubmed: 16399151
Cancer Res. 1978 Nov;38(11 Pt 1):3769-73
pubmed: 212177
Lancet. 2005 Apr 30-May 6;365(9470):1591-5
pubmed: 15866314
Nat Rev Genet. 2017 Jul;18(7):441-451
pubmed: 28555657
Clin Epigenetics. 2011 Apr;2(1):55-61
pubmed: 22704269
J Bone Miner Res. 2014 Sep;29(9):1917-25
pubmed: 24861883
Scand J Clin Lab Invest Suppl. 2012;243:32-40
pubmed: 22536760
Osteoporos Int. 2015 Apr;26(4):1449-51
pubmed: 25448839
Biosci Biotechnol Biochem. 2011;75(2):208-13
pubmed: 21307571
Lancet Diabetes Endocrinol. 2016 May;4(5):393-402
pubmed: 26944421
J Steroid Biochem Mol Biol. 2016 May;159:102-9
pubmed: 26953979
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:207-14
pubmed: 24128439
Front Physiol. 2014 Apr 29;5:164
pubmed: 24808866
Mol Cell Endocrinol. 2017 Sep 15;453:14-21
pubmed: 28315703
Nat Genet. 2009 Feb;41(2):178-186
pubmed: 19151715
N Engl J Med. 2008 Jul 3;359(1):61-73
pubmed: 18596274
J Bone Miner Res. 2017 Oct;32(10):2030-2040
pubmed: 28419547
Br J Nutr. 2007 Jun;97(6):1064-73
pubmed: 17433129
J Nutr. 2009 Jun;139(6):1054-60
pubmed: 19339705
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
J Bone Miner Res. 2014 Mar;29(3):600-7
pubmed: 23907847
Am J Clin Nutr. 1993 Dec;58(6):839-45
pubmed: 8249864
Nat Rev Genet. 2012 May 29;13(7):484-92
pubmed: 22641018
Health Technol Assess. 2014 Jul;18(45):1-190
pubmed: 25025896
Front Genet. 2014 Oct 13;5:308
pubmed: 25352859
Nature. 2015 Jan 15;517(7534):321-6
pubmed: 25592537